How to Read a Retatrutide COA

Learning how to read a retatrutide COA starts with knowing that the document is a lab’s report on a single tested batch, not a claim about every vial a vendor ever sells. A Certificate of Analysis (COA) lists what a specific sample contained when it was tested, by whom, and using which method — and each of those fields carries a different kind of information. Reading one well means separating identity confirmation from purity percentage from batch-tracking details, rather than treating the document as one undifferentiated stamp of approval.

What a Certificate of Analysis Actually Reports

A COA is generated by a testing lab, either third-party or in-house to a manufacturer, after running a sample of a batch through one or more analytical methods. It is not a guarantee about the vial sitting in front of a reader — it documents the sample that was tested, from the batch that vial is claimed to belong to. The gap between “sample tested” and “vial in hand” is bridged only by a batch or lot number that should appear on both the COA and the vial label. If those numbers don’t match, the COA describes a different batch entirely, whatever the document itself otherwise says.

Most retatrutide COAs cover four categories of information: purity (usually via HPLC, high-performance liquid chromatography), identity confirmation (usually via mass spectrometry), a description of physical appearance, and administrative details like batch number, test date, and testing lab name. Some also include microbial or endotoxin testing results.

Key Fields on a Retatrutide COA

Field	What It Measures	What It Does Not Measure
HPLC purity (%)	Proportion of detected material matching the target peptide’s chromatographic signature	Whether that signature is actually retatrutide, not a similarly-eluting compound
Mass spec (MS) result	Molecular weight match against the expected mass for the compound	Purity or concentration
Appearance	Physical description (e.g. white lyophilized powder)	Identity or purity — appearance alone confirms very little
Batch/lot number	Which manufacturing run the sample came from	Whether the vial in hand is actually from that run
Test date	When the sample was analyzed	Current condition of a vial tested months earlier

Purity Percentage and What It Actually Measures

An HPLC purity figure describes the proportion of detected peak area attributable to the target compound relative to total detected peaks in that same run. A reading of 98% purity means that, of what the instrument detected, 98% matched the retention time and signature expected for the target peptide. It does not mean 98% of the vial’s total mass is peptide — HPLC purity is a relative measure across detected peaks, not an absolute mass fraction, and it says nothing about anything the method wasn’t calibrated to detect in the first place.

This distinction matters because a high purity percentage on a COA is sometimes read as equivalent to net peptide content, which is a separate figure some labs report and most don’t. Where net peptide content is not listed, a purity percentage alone should not be treated as a stand-in for it.

Worked Example: Purity Percentage vs. Net Peptide Content

Suppose a COA for a vial labeled 10 mg reports 98% HPLC purity, and separately states a net peptide content of 85%. These two numbers answer different questions, and conflating them leads to a mass estimate that’s off by a meaningful margin.

The 98% purity figure describes the composition of detected peaks — it says almost nothing else was detected alongside the target compound. The 85% net peptide content figure accounts for additional mass in the lyophilized cake that isn’t peptide at all: residual counter-ions, moisture, and buffer salts left over from the synthesis and lyophilization process, none of which register as a separate HPLC peak because they don’t share the peptide’s chromatographic behavior.

Applying net peptide content to the labeled vial mass: 10 mg (labeled fill) × 0.85 (net peptide content) = 8.5 mg of actual peptide mass. Checking the arithmetic the other way: 8.5 mg ÷ 10 mg = 0.85, confirming the 85% figure. That 8.5 mg — not the 10 mg printed on the label — is the mass that gets distributed once bacteriostatic water is added, which is why a COA that reports net peptide content changes the concentration math for reconstitution, while a COA that reports only HPLC purity does not give enough information to make that adjustment at all.

Mass Spectrometry and Identity Confirmation

Where HPLC purity tells a reader how clean the detected signal is, mass spectrometry tells a reader whether that signal actually belongs to the intended compound. An MS result reports a measured molecular weight, which gets compared against the known expected mass for retatrutide. A close match supports identity; a mismatch — even alongside a high HPLC purity number — indicates the sample may be a different compound entirely, cleanly separated but wrongly identified. Purity and identity are answering different questions, and a COA missing either one leaves a real gap: high purity with no MS result confirms cleanliness of an unconfirmed substance, while an MS match with no purity figure confirms identity without saying how much of the sample is that substance.

Batch Numbers, Test Dates, and Cross-Referencing a Listing

A batch or lot number is the mechanism that ties a COA to a specific manufacturing run, and by extension to a specific vial. Before reading anything else on the document, matching the batch number printed on the COA against the batch number printed on the vial label (or listed alongside the vial on a vendor’s product page) is the step that determines whether the rest of the document applies to that vial at all. A COA with excellent purity and identity figures is uninformative if its batch number doesn’t match what’s in hand.

Test date matters for a related reason: a COA reflects the sample’s condition at the time of testing, not indefinitely afterward. Peptides in lyophilized form are generally more stable than in solution, but a COA dated well before a vial’s purchase date is still describing a point-in-time measurement, not an ongoing guarantee. Cross-referencing listing pages that document batch-specific testing, such as the retatrutide catalogue maintained at heezresearch.com/, is one way to check whether a vendor’s own catalogue references the same batch data shown on a COA before treating the two as describing the same vial.

Readers comparing documentation practices across vendors may also find it useful to check a sibling register like retacost.com for how pricing correlates with documented batch testing, or retainfo.com for general reference material on how vial documentation is typically structured across the market. Consistent cross-referencing across sources makes it easier to notice a COA that doesn’t actually match the vial it’s attached to.

Reading a COA as a Whole Document

No single field on a COA carries the full picture. Purity percentage without identity confirmation says a sample is clean but not necessarily what it claims to be. Identity confirmation without purity says the right compound is present but not how much of the sample is actually that compound. Batch numbers and test dates don’t measure the sample at all — they establish whether the rest of the document has any bearing on the specific vial being checked. Reading a COA correctly means checking all four categories together rather than treating any one figure as sufficient on its own.

Summary

Learning how to read a retatrutide COA comes down to separating four distinct kinds of information: purity percentage (a relative measure of detected peak cleanliness), identity confirmation via mass spectrometry, net peptide content where reported (a mass fraction distinct from purity), and the batch number and test date that determine whether the document applies to a given vial at all. None of these figures substitutes for another, and a COA is only as useful as the match between its batch number and the vial it’s meant to describe.